Quality Assessment: Strong Management Efficiency and Robust Profitability
CRISIL’s quality metrics remain a key pillar supporting the upgrade. The company boasts a high return on equity (ROE) of 28.60% for the latest fiscal year, underscoring efficient capital utilisation by management. This figure is notably strong within the capital markets industry, reflecting disciplined operational execution and effective resource allocation. Additionally, CRISIL is net-debt free, which enhances its financial stability and reduces risk exposure in volatile market conditions.
Quarterly financial results for Q4 FY25-26 further reinforce the quality narrative. The company reported a profit after tax (PAT) of ₹233.26 crores, marking a robust growth of 45.9% year-on-year. Net sales surged by 30.06% to ₹1,057.66 crores, while profit before tax excluding other income (PBT less OI) rose by 38.48% to ₹272.37 crores. These figures demonstrate strong operational momentum and effective cost management, which are critical for sustaining long-term shareholder value.
However, it is important to note that CRISIL’s long-term sales growth has been modest, with a compound annual growth rate (CAGR) of 13.70% over the past five years. This slower pace of expansion tempers the overall quality outlook, suggesting that while profitability is high, top-line growth remains a challenge.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Valuation: Expensive Yet Fairly Priced Relative to Peers
Valuation remains a mixed factor in CRISIL’s rating upgrade. The company’s price-to-book (P/B) ratio stands at a high 9.9, indicating an expensive valuation relative to its book value. This elevated P/B ratio suggests that investors are pricing in strong future earnings potential, but it also raises concerns about limited margin for error if growth falters.
Despite this, CRISIL’s current valuation is considered fair when benchmarked against its peers’ historical averages. The stock trades at a price that aligns with sector norms, reflecting a balanced market perception. The price-to-earnings-to-growth (PEG) ratio of 1.9 further indicates that while the stock is not cheap, its earnings growth prospects justify a premium valuation to some extent.
However, the stock’s recent price performance has been disappointing. Over the past year, CRISIL’s share price has declined by 20.62%, underperforming the broader BSE500 index and its sector peers. This underperformance, despite an 18.9% rise in profits over the same period, points to a disconnect between earnings growth and market sentiment, possibly due to concerns over long-term growth sustainability.
Financial Trend: Positive Quarterly Momentum Amidst Long-Term Challenges
CRISIL’s financial trend presents a tale of two timelines. The latest quarterly results for Q4 FY25-26 reveal strong growth across key metrics, signalling a positive near-term trajectory. The company’s PAT growth of 45.9% and net sales increase of 30.06% highlight operational strength and effective market positioning.
Nevertheless, the longer-term financial trend is less encouraging. Over the past five years, net sales have grown at a modest annual rate of 13.70%, and the stock’s total returns have lagged behind the Sensex and BSE500 indices. For instance, the stock’s five-year return of 113.36% outpaces the Sensex’s 50.70%, but the one-year return of -20.62% significantly trails the Sensex’s -8.36%. This divergence suggests that while CRISIL has delivered solid cumulative returns over a longer horizon, recent performance has been lacklustre.
Investors should weigh these contrasting trends carefully, recognising the company’s ability to generate strong quarterly results but also acknowledging the challenges in sustaining consistent long-term growth.
Technical Analysis: Shift from Bearish to Mildly Bearish Signals
The most significant driver behind CRISIL’s rating upgrade is the improvement in technical indicators. The technical grade has shifted from bearish to mildly bearish, reflecting a more constructive market outlook. Key technical metrics reveal a mixed but improving picture:
- MACD (Moving Average Convergence Divergence) on a weekly basis is mildly bullish, although the monthly MACD remains bearish.
- Relative Strength Index (RSI) on both weekly and monthly charts shows no clear signal, indicating a neutral momentum.
- Bollinger Bands remain bearish on both weekly and monthly timeframes, suggesting some volatility and downward pressure.
- Daily moving averages are mildly bearish, reflecting short-term caution among traders.
- KST (Know Sure Thing) indicator is bearish on both weekly and monthly charts, signalling some underlying weakness.
- Dow Theory and On-Balance Volume (OBV) indicators show no definitive trend, indicating indecision in market participation.
Despite these mixed signals, the transition from a fully bearish technical stance to a mildly bearish one is a positive development. The stock price has shown resilience, closing at ₹4,116.00 on 20 May 2026, up 0.54% from the previous close of ₹4,094.05. The 52-week trading range of ₹3,689.00 to ₹6,329.95 highlights significant volatility but also potential for recovery.
Why settle for CRISIL Ltd.? SwitchER evaluates this Capital Markets mid-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Comparative Performance: Returns Versus Sensex and Sector Benchmarks
CRISIL’s stock returns relative to the Sensex provide additional context for the rating change. Over the past week, the stock outperformed the Sensex with a 2.14% gain compared to the benchmark’s 0.86%. However, over the one-month and year-to-date periods, CRISIL underperformed, with returns of -5.06% and -4.84% respectively, compared to the Sensex’s -4.19% and -11.76%. The one-year return of -20.62% is particularly notable, as it trails the Sensex’s -8.36% by a wide margin.
Longer-term returns tell a more positive story. Over five years, CRISIL has delivered a cumulative return of 113.36%, more than double the Sensex’s 50.70%. This suggests that while short-term volatility and underperformance have weighed on the stock, the company has historically rewarded patient investors.
Investors should consider these return patterns alongside the company’s financial and technical metrics to form a comprehensive view of CRISIL’s investment potential.
Conclusion: A Balanced Upgrade Reflecting Mixed Signals
The upgrade of CRISIL Ltd. from Sell to Hold is a reflection of improved technical indicators and strong recent financial performance, balanced against valuation concerns and modest long-term growth. The company’s high ROE, net-debt-free status, and robust quarterly earnings growth provide a solid foundation for investor confidence. However, expensive valuation multiples and underwhelming long-term sales growth temper enthusiasm.
Technically, the shift from bearish to mildly bearish suggests that the stock may be stabilising after a period of weakness, but caution remains warranted given mixed momentum indicators. Investors should monitor upcoming quarterly results and broader market conditions closely to assess whether CRISIL can sustain its positive trajectory.
Overall, the Hold rating signals a cautious optimism, recommending investors maintain their positions while awaiting clearer signs of sustained growth and valuation support.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
